Moderate anti-VEGF therapy may lead to ‘vascular normalization’, which is characterized by an attenuation of hyperpermeability, increased vascular pericyte coverage, a more normal basement membrane, and a resultant reduction in tumor hypoxia and interstitial fluid pressure. Here, VEGFA is linked to neoplasm.